Heron Therapeutics Ownership | Who Owns Heron Therapeutics?
Heron Therapeutics Ownership Summary
Heron Therapeutics is owned by 23.46% institutional investors, 0.67% insiders, and 75.87% retail investors. Rubric capital management lp is the largest institutional shareholder, holding 17.40% of HRTX shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 3.07% of its assets in Heron Therapeutics shares.
HRTX Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Heron Therapeutics | 23.46% | 0.67% | 75.87% |
Sector | Healthcare Stocks | 279.42% | 10.64% | -190.05% |
Industry | Biotech Stocks | 64.05% | 10.69% | 25.27% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Rubric capital management lp | 26.71M | 17.40% | $58.77M |
Blackrock funding, inc. /de | 8.59M | 5.62% | $13.14M |
Adage capital partners gp | 8.50M | 5.56% | $13.01M |
Blackrock | 8.33M | 5.51% | $29.14M |
Vanguard group | 8.16M | 5.34% | $12.48M |
Velan capital investment management lp | 6.99M | 4.55% | $15.37M |
Tejara capital | 4.66M | 3.05% | $7.13M |
Palisade capital management, lp | 3.93M | 2.57% | $6.01M |
D. e. shaw | 3.72M | 2.44% | $5.70M |
State street | 3.15M | 2.06% | $4.81M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Velan capital investment management lp | 6.99M | 15.81% | $15.37M |
Tejara capital | 4.66M | 4.67% | $7.13M |
Stonepine capital management | 796.10K | 1.70% | $1.75M |
Jw asset management | 2.29M | 1.67% | $3.51M |
Congress park capital | 2.46M | 1.36% | $3.76M |
Orchard capital management | 1.88M | 1.12% | $2.84M |
Rubric capital management lp | 26.71M | 1.05% | $58.77M |
Cm management | 700.00K | 0.96% | $1.07M |
Richmond brothers | 642.34K | 0.63% | $982.78K |
Clearline capital lp | 1.81M | 0.37% | $2.77M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Millennium management | 1.40M | 0.00% | 1.18M |
Blackrock | 8.33M | 0.00% | 1.04M |
Morgan stanley | 767.86K | 0.00% | 568.86K |
Congress park capital | 2.46M | 1.36% | 477.42K |
Quinn opportunity partners | 380.00K | 0.04% | 380.00K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Orbimed advisors | - | - | -6.51M |
Point72 asset management | - | - | -4.78M |
Qube research | - | - | -1.15M |
Goldman sachs group | 655.16K | 0.00% | -1.05M |
Renaissance | 1.19M | 0.00% | -819.40K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Quinn opportunity partners | 380.00K | 0.04% | 380.00K | $581.40K |
Bridgeway capital management | 300.00K | 0.01% | 300.00K | $459.00K |
J. goldman & co lp | 270.10K | 0.01% | 270.10K | $413.25K |
Raymond james financial | 135.72K | 0.00% | 135.72K | $207.66K |
Biltmore family office | 101.47K | 0.03% | 101.47K | $155.25K |
Sold Out
Holder | Change |
---|---|
Allspring global investments | -1.00 |
Toronto dominion bank | -9.00 |
Lindbrook capital | -16.00 |
Ifp advisors | -35.00 |
Northwestern mutual wealth management | -53.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Mar 31, 2025 | 7 | -95.81% | 36,006,112 | -68.67% | 23 | 0.41% | 4 | -94.12% | - | -100.00% |
Dec 31, 2024 | 90 | -48.86% | 38,837,514 | -68.12% | 25 | 0.40% | 37 | -57.95% | 24 | -36.84% |
Sep 30, 2024 | 175 | -9.79% | 121,805,039 | -6.02% | 79 | 1.08% | 87 | -23.01% | 38 | -2.56% |
Jun 30, 2024 | 194 | 17.58% | 129,609,462 | 8.61% | 85 | 1.36% | 113 | 59.15% | 39 | -17.02% |
Mar 31, 2024 | 165 | 5.77% | 119,336,211 | 6.43% | 79 | 1.33% | 71 | -4.05% | 47 | 27.03% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard US Total Market Shares ETF | 4.68M | 3.07% | - |
Vanguard Total Stock Mkt Idx Inv | 4.68M | 3.07% | - |
iShares Russell 2000 ETF | 3.63M | 2.38% | -68.88K |
Palisade Small Cap Core Equity | 3.19M | 2.09% | -141.42K |
Biotech Growth Ord | 2.58M | 1.70% | 2.58M |
Vanguard Institutional Extnd Mkt Idx Tr | 2.22M | 1.46% | -40.12K |
Franklin US Small Cap Growth Equity | 1.80M | 1.19% | - |
Fidelity Small Cap Index | 1.20M | 0.78% | - |
iShares Russell 2000 Value ETF | 1.17M | 0.77% | 869.00 |
State St Russell Sm/Mid Cp® Indx NL Cl C | 851.80K | 0.56% | 3.84K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Aug 08, 2025 | Rubric Capital Management LP | - | Buy | $3.58M |
Aug 08, 2025 | Rubric Capital Management LP | - | Buy | - |
Aug 08, 2025 | Rubric Capital Management LP | - | Buy | - |
Aug 08, 2025 | Morgan Adam | - | Buy | $105.02K |
Aug 08, 2025 | Morgan Adam | - | Buy | $2.65M |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2025 Q2 | - | - |
2025 Q1 | - | - |
2024 Q4 | - | - |
2024 Q3 | - | - |
2024 Q2 | - | - |
HRTX Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools